Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$2.22B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$2.02B |
| 3 |
Amazon
AMZN
|
+$1.98B |
| 4 |
EPAM Systems
EPAM
|
+$1.88B |
| 5 |
Apple
AAPL
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.27B |
| 2 |
Netflix
NFLX
|
+$2.99B |
| 3 |
Microsoft
MSFT
|
+$1.94B |
| 4 |
Home Depot
HD
|
+$1.69B |
| 5 |
CSX Corp
CSX
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.08% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 12.89% |
| 4 | Financials | 10.35% |
| 5 | Industrials | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SF
176
Stifel
SF
$12.8B
| $413M | 0.1% |
9,125,048
+4,307
| +0% | +$207K |
|
177
Marqeta
MQ
$1.68B
| $410M | 0.1% |
9,285,543
+7,220,549
| +350% | +$335M |
|
178
Citigroup
C
$232B
| $405M | 0.1% |
7,591,327
+82,641
| +1% | +$5.1M |
|
179
Mattel
MAT
$4.18B
| $402M | 0.1% |
18,082,737
-12,239
| -0.1% | -$280K |
|
|
SIVB
180
DELISTED
SVB Financial Group
SIVB
| $400M | 0.1% |
714,766
+212,802
| +42% | +$129M |
|
181
Bank of America
BAC
$454B
| $395M | 0.1% |
+9,594,396
| New | +$433M |
|
182
Grab
GRAB
$14.8B
| $379M | 0.09% |
108,322,250
+36,542,740
| +51% | +$185M |
|
183
Nu Holdings
NU
$66.9B
| $368M | 0.09% |
49,252,241
+4,519,651
| +10% | +$36.3M |
|
184
Haemonetics
HAE
$4.14B
| $345M | 0.09% |
5,452,006
+3,402,873
| +166% | +$185M |
|
185
Paycom
PAYC
$9.4B
| $341M | 0.08% |
985,138
-1,003,800
| -50% | -$337M |
|
186
Entergy
ETR
$50.3B
| $339M | 0.08% |
5,802,678
-2,991,146
| -34% | -$164M |
|
187
Thor Industries
THO
$4.09B
| $337M | 0.08% |
4,282,838
-580,431
| -12% | -$53.4M |
|
188
East-West Bancorp
EWBC
$18.6B
| $335M | 0.08% |
4,238,889
-1,839
| -0% | -$155K |
|
189
IQVIA
IQV
$39.1B
| $334M | 0.08% |
1,442,596
+162,879
| +13% | +$38.6M |
|
190
Cullen/Frost Bankers
CFR
$10.5B
| $333M | 0.08% |
2,408,656
+676,467
| +39% | +$94.1M |
|
191
SouthState Bank Corp
SSB
$10.8B
| $331M | 0.08% |
4,051,286
+955,920
| +31% | +$82.4M |
|
192
Nutrien
NTR
$32B
| $326M | 0.08% |
3,132,262
+394
| +0% | +$32.6K |
|
193
Freshpet
FRPT
$3.47B
| $323M | 0.08% |
3,151,546
-12,899
| -0.4% | -$1.21M |
|
194
Kimco Realty
KIM
$16.3B
| $323M | 0.08% |
13,084,781
+2,194
| +0% | +$53K |
|
|
PXD
195
DELISTED
Pioneer Natural Resource Co.
PXD
| $320M | 0.08% |
1,279,531
-517,889
| -29% | -$117M |
|
|
OSH
196
DELISTED
Oak Street Health, Inc.
OSH
| $319M | 0.08% |
11,852,080
+4,491,941
| +61% | +$94.7M |
|
197
Dow Inc
DOW
$22B
| $318M | 0.08% |
4,996,270
-2,865,950
| -36% | -$173M |
|
|
APTV.PRA
198
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $314M | 0.08% |
2,299,796
+100
| +0% | +$15.1K |
|
199
Alexandria Real Estate Equities
ARE
$8.26B
| $312M | 0.08% |
1,550,791
-341,594
| -18% | -$66.7M |
|
|
MRSH
200
Marsh
MRSH
$90.3B
| $312M | 0.08% |
1,830,548
+1,406,293
| +331% | +$222M |
|
Similar funds
Capital Research Global Investors's Q1 2022 Portfolio in Review
As of Q1 2022, Capital Research Global Investors held 468 positions worth $405B, down 11% from $453B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital Research Global Investors's Q1 2022 filing shows 28 new, 180 increased, 190 reduced and 28 closed positions. Its largest new stake was Halliburton: 17,891,897 shares worth $678M. The largest sale was Gilead Sciences, an estimated $3.27B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q1 2022 buy was Halliburton: 17,891,897 shares worth $678M.
- Capital Research Global Investors added most to GE Aerospace in Q1 2022, an estimated $2.22B increase.
- Capital Research Global Investors's biggest Q1 2022 reduction was Gilead Sciences, cutting an estimated $3.27B.
- Capital Research Global Investors fully exited PayPal in Q1 2022, selling an estimated $769M.
- Capital Research Global Investors's ten largest holdings make up 28% of its $405B portfolio in Q1 2022.
- Capital Research Global Investors opened 28 new positions and closed 28 in Q1 2022.
- Capital Research Global Investors's portfolio value fell 11% quarter-over-quarter to $405B.
Based on Capital Research Global Investors's 13F filing for Q1 2022, filed 16 May 2022.